Genomic Correlates of DNA Damage in Breast Cancer Subtypes

by Esther Cabañas Morafraile, Javier Pérez-Peña, Jesús Fuentes-Antrás, Aránzazu Manzano, Pedro Pérez-Segura, Atanasio Pandiella, Eva M. Galán-Moya, Alberto Ocaña
Published 2021-04-01

Pathogenic Microenvironment from Diabetic–Obese Visceral and Subcutaneous Adipocytes Activating Differentiation of Human Healthy Preadipocytes Increases Intracellular Fat, Effect o...

by Lesgui Alviz, David Tebar-García, Raquel Lopez-Rosa, Eva M. Galan-Moya, Natalia Moratalla-López, Gonzalo L. Alonso, Eduardo Nava, Sílvia Llorens
Published 2021-03-01

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.

by María Del Mar Noblejas-López, Sara Morcillo-García, Cristina Nieto-Jiménez, Miriam Nuncia-Cantarero, Balázs Győrffy, Eva M Galan-Moya, Atanasio Pandiella, Alberto Ocaña
Published 2018-01-01

MZ1 co-operates with trastuzumab in HER2 positive breast cancer

by María del Mar Noblejas-López, Cristina Nieto-Jiménez, Eva M. Galán-Moya, David Tebar-García, Juan Carlos Montero, Atanasio Pandiella, Miguel Burgos, Alberto Ocaña
Published 2021-03-01

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

by María del Mar Noblejas-López, Cristina Nieto-Jimenez, Miguel Burgos, Mónica Gómez-Juárez, Juan Carlos Montero, Azucena Esparís-Ogando, Atanasio Pandiella, Eva M. Galán-Moya, Alberto Ocaña
Published 2019-08-01

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

by Cristina Nieto-Jimenez, Ana Alcaraz-Sanabria, Sandra Martinez-Canales, Veronica Corrales-Sanchez, Juan Carlos Montero, Miguel Burgos, Miriam Nuncia-Cantarero, Atanasio Pandiella, Eva M. Galan-Moya, Alberto Ocaña
Published 2020-11-01

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.

by Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, Javier Perez-Peña, Miriam Nuncia-Cantarero, Balázs Győrffy, Eitan Amir, Atanasio Pandiella, Eva M Galan-Moya, Alberto Ocana
Published 2019-01-01

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

by María del Mar Noblejas-López, Cristina Nieto-Jiménez, Sara Morcillo García, Javier Pérez-Peña, Miriam Nuncia-Cantarero, Fernando Andrés-Pretel, Eva M. Galán-Moya, Eitan Amir, Atanasio Pandiella, Balázs Győrffy, Alberto Ocana
Published 2019-10-01

Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC.

by Eva M Galan-Moya, Miguel A de la Cruz-Morcillo, Maria Llanos Valero, Juan L Callejas-Valera, Pedro Melgar-Rojas, Javier Hernadez Losa, Mayte Salcedo, Antonio Fernández-Aramburo, Santiago Ramon y Cajal, Ricardo Sánchez-Prieto
Published 2011-01-01

ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy.

by Clara I Aceves-Luquero, Anupriya Agarwal, Juan L Callejas-Valera, Laura Arias-González, Azucena Esparís-Ogando, Luis del Peso Ovalle, Itxaso Bellón-Echeverria, Miguel A de la Cruz-Morcillo, Eva M Galán Moya, Inmaculada Moreno Gimeno, Juan C Gómez, Michael W Deininger, Atanasio Pandiella, Ricardo Sánchez Prieto
Published 2009-07-01